Cargando…

Correction: Medaka as a model for human nonalcoholic steatohepatitis

Detalles Bibliográficos
Autores principales:	Matsumoto, Toshihiko, Terai, Shuji, Oishi, Toshiyuki, Kuwashiro, Shinya, Fujisawa, Koichi, Yamamoto, Naoki, Fujita, Yusuke, Hamamoto, Yoshihiko, Furutani-Seiki, Makoto, Nishina, Hiroshi, Sakaida, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339108/ https://www.ncbi.nlm.nih.gov/pubmed/37403634 http://dx.doi.org/10.1242/dmm.050367

Ejemplares similares

Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation
por: Kuwashiro, Shinya, et al.
Publicado: (2011)

Circadian variations in the liver metabolites of medaka (Oryzias latipes)
por: Fujisawa, Koichi, et al.
Publicado: (2016)

Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging
por: Fujisawa, Koichi, et al.
Publicado: (2015)

Correction: Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging
por: Fujisawa, Koichi, et al.
Publicado: (2015)

Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver
por: Fujisawa, Koichi, et al.
Publicado: (2017)

Assessment of high-fat-diet-induced fatty liver in medaka
por: Fujisawa, Koichi, et al.
Publicado: (2018)

Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose
por: Fujisawa, Koichi, et al.
Publicado: (2021)

Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease
por: Nagoya, Takuro, et al.
Publicado: (2019)

Seasonal variations in photoperiod affect hepatic metabolism of medaka (Oryzias latipes)
por: Fujisawa, Koichi, et al.
Publicado: (2021)

Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)
por: Goto, Ryo, et al.
Publicado: (2019)

Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4
por: Fujisawa, Koichi, et al.
Publicado: (2016)

Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model
por: Sasaki, Ryo, et al.
Publicado: (2020)

Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
por: Yamamoto, Naoki, et al.
Publicado: (2016)

The expanding role of fish models in understanding non-alcoholic fatty liver disease
por: Asaoka, Yoichi, et al.
Publicado: (2013)

Histological and Transcriptomic Analysis of Adult Japanese Medaka Sampled Onboard the International Space Station
por: Murata, Yasuhiko, et al.
Publicado: (2015)

Image Correction Methods for Regions of Interest in Liver Cirrhosis Classification on CNNs
por: Mitani, Yoshihiro, et al.
Publicado: (2022)

Profiling of the circadian metabolome in thioacetamide‐induced liver cirrhosis in mice
por: Fujisawa, Koichi, et al.
Publicado: (2017)

Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy
por: Hirose, Kanae, et al.
Publicado: (2016)

Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
por: Tanabe, Norikazu, et al.
Publicado: (2017)

Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells
por: Fujisawa, Koichi, et al.
Publicado: (2020)

An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells
por: Fujisawa, Koichi, et al.
Publicado: (2022)

Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database
por: Terai, Shuji, et al.
Publicado: (2021)

Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites
por: Goto, Atsushi, et al.
Publicado: (2014)

Radiation Hybrid Maps of Medaka Chromosomes LG 12, 17, and 22
por: Su, Feng, et al.
Publicado: (2007)

CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma
por: Nishina, Sohji, et al.
Publicado: (2022)

A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates
por: Suda, Takeshi, et al.
Publicado: (2019)

Evaluation of the effects of ascorbic acid on metabolism of human mesenchymal stem cells
por: Fujisawa, Koichi, et al.
Publicado: (2018)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

MicroRNAs and Nonalcoholic Steatohepatitis: A Review
por: Morishita, Asahiro, et al.
Publicado: (2023)

Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis
por: Yamaguchi, Takashi, et al.
Publicado: (2022)

A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy
por: Saeki, Issei, et al.
Publicado: (2015)

NUPR1 acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamine
por: Matsunaga, Kazuhito, et al.
Publicado: (2019)

Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion
por: Minami, Yoshito, et al.
Publicado: (2023)

TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion
por: Hisanaga, Takuro, et al.
Publicado: (2011)

IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism
por: Azuma, Yasu-Taka, et al.
Publicado: (2021)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9d3kqc90926pg825t5edo7k1f1